
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
RARγ/Retinoic Acid Receptor γ CRISPR/Cas9 KO Plasmid (m) | sc-422601 | 20 µg | $397.00 | |||
RARγ/Retinoic Acid Receptor γ HDR Plasmid (m) | sc-422601-HDR | 20 µg | $445.00 |
Rarg encodes retinoic acid receptor gamma (RARγ), a ligand-activated nuclear receptor that heterodimerizes with RXR to bind retinoic acid response elements and regulate transcriptional programs controlling differentiation, morphogenesis, and tissue homeostasis. RARγ integrates retinoid metabolism and signaling to modulate chromatin state and lineage-specific gene expression, influencing processes such as skeletal development, epidermal maturation, and immune cell function. In mouse models, altered Rarg activity perturbs developmental patterning and stem/progenitor cell behavior, providing mechanistic links to dysregulated differentiation and oncogenic transcriptional states. Rarg is therefore widely studied in pathways governing cell fate decisions, nuclear receptor crosstalk, and transcriptional control during development and disease modeling.
RARγ/Retinoic Acid Receptor γ CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Rarg gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Rarg locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, RARγ/Retinoic Acid Receptor γ HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Rarg target site.
When co-transfected with RARγ/Retinoic Acid Receptor γ CRISPR/Cas9 KO Plasmid (m):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Rarg locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.